|Mr. Jin-Hyung Park||Chief Exec. Officer and Director||N/A||N/A||1967|
|Mr. Han-Sang Cho||Sr. Managing Director||N/A||N/A||1967|
|Mr. Chan-Il Jeong||Sr. Managing Director||N/A||N/A||1969|
|Mr. Hee-Don An||Managing Director||N/A||N/A||1968|
|Ms. Sun-Mee Han||Managing Director||N/A||N/A||1973|
|Mr. Jung-Goo Seo||Vice-Pres and Director||N/A||N/A||1962|
NanoEnTek Inc. engages in the research and development, production, and sale of life-science lab equipment, in vitro diagnostic medical devices, point of care diagnostic devices, and related consumables and solutions in Korea and internationally. It provides FREND system, a quantitative fluorescence immunoassay analyzer; BUDDI, a rapid diagnostic test analyzer; rapid diagnostic test items; ADAM-rWBC, an analytical device for counting the residual white blood cells; ADAMII, a fluorescence stem cell counter; EVE, a benchtop counter to measure cell count and viability; Arthur/fluorescence cell counters; automated somatic cell counters; live-cell imaging system; and disposable hemocytometers. The company was founded in 2000 and is headquartered in Seoul, South Korea.
NanoenTek,Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.